Welo Life Sciences: Built for Life Sciences Translation, Regulatory Content, and Global ComplianceÂ
This is the environment where life sciences translation, regulatory content management, and multilingual compliance are not optional, they are foundational.
Regulated content doesn’t forgive approximation. A mistranslation in a clinical trial protocol, a terminology inconsistency in a regulatory submission, an audit trail that doesn’t hold up to scrutiny. The consequences in life sciences are not abstract. They affect timelines, approvals, and ultimately, patients.
That’s the environment Welocalize has been working in for years. And it’s exactly why we’ve launched Welo Life Sciences, a dedicated brand within Welo Global, built specifically for pharmaceutical companies, biotech organizations, contract research organizations, and medical device manufacturers operating at global scale. This is the environment where life sciences translation, regulatory content management, and multilingual compliance are not optional, they are foundational.
This isn’t a rebrand. It’s a sharper focus on work we’ve been doing for a long time, and a clear signal of where we’re investing next.
Why Does Life Sciences Translation Requires a Dedicated Approach?
The life sciences sector has distinct needs that don’t map neatly onto general language services. Regulatory submissions require terminology precision that’s audit-ready across languages. Clinical trial documentation must be consistent, traceable, and compliant with multiple governing frameworks simultaneously. Pharmacovigilance content carries safety obligations that leave no room for ambiguity.
For years, our teams have supported clients across all of these areas. Quietly, rigorously, and at scale. Welo Life Sciences gives that work its own identity, its own investment roadmap, and its own voice in the market.
As Cristina Pardo, General Manager of Welo Life Sciences, puts it: “We’ve been doing this work for a long time. Navigating complex regulatory environments, supporting submissions across dozens of markets, helping clients get the right content to the right place at the right time. What’s changed is that we now have a dedicated brand that reflects the depth of that specialization, and a genuine commitment to keep building capabilities that match what this sector actually needs.”
Life Sciences Translation Services Across the Content Lifecycle
Our life sciences translation and localization services are designed to support regulated content at every stage, from early clinical development through to post-market activities. That includes:
- Clinical trial documentation and patient-facing materials
- Regulatory submissions and market access content
- Pharmacovigilance and safety reporting
- Product launch and commercialization materials across global markets
These services are delivered across languages and regions, supporting global clinical trials, regulatory submissions, and product commercialization. Our focus on life sciences translation ensures consistency, traceability, and compliance across every stage of the content lifecycle.
We also integrate directly into leading clinical trial management systems (CTMS), so our solutions work within the operational and regulatory frameworks our clients already rely on, not around them. All of this is delivered within a validated, audit-ready infrastructure, backed by seven ISO certifications.
Precision at Scale: Not a Trade-Off
One of the persistent challenges in life sciences is the tension between speed and compliance. The pressure to accelerate timelines is real. So is the cost of getting it wrong.
Our model is built on the belief that these don’t have to be in conflict. Domain-specific linguists, regulatory subject-matter experts, and secure global delivery infrastructure work together to ensure that accuracy is built into the process, not added at the end. We don’t treat compliance as a constraint. We treat it as the baseline from which everything else is built.
A Clear Commitment to What’s Coming
Launching Welo Life Sciences is also a statement about investment. We are actively expanding specialised capabilities, developing technologies designed for regulated workflows, and deepening the integrations that help life sciences organisations move from content creation to submission without losing momentum.
The demand for precise, compliant, scalable global content is only growing. New markets. New modalities. New regulatory frameworks. The organisations navigating that landscape need a partner who understands the territory, not as one service line among many, but as a focused area of genuine expertise.
Welo Life Sciences is one of five specialized brands within Welo Global, alongside Welocalize, Adapt, Park IP, and Welo Data. Each exists to serve a specific customer segment with greater depth and a sharper operational focus. For life sciences organizations, that means a partner built around the complexity of your work, not adapted to it after the fact.
The Work Continues. Now It Has a Name.
We’ve supported the life sciences sector through regulatory shifts, global expansions, and submissions that leave no room for error. That experience doesn’t change with a new brand. What changes is the clarity of our commitment and the momentum behind it.
If your organisation is managing regulated content across global markets, we’d like to talk.
Explore our life sciences translation and regulatory content solutions.
FAQs: Life Sciences Translation and Regulatory Content
Life sciences translation services include the translation and localization of regulated content for pharmaceutical companies, biotech organizations, CROs, and medical device manufacturers. This covers clinical trials, regulatory submissions, patient materials, and safety reporting, all of which must meet strict standards for accuracy, consistency, and compliance across global markets.
Clinical trial translation and regulatory translation services are essential because content must be precise, traceable, and consistent across languages. Even small errors can delay approvals, introduce compliance risks, or impact patient safety. Translation in this context is part of the regulatory process and must meet audit-ready standards.
Regulatory compliance is built into life sciences translation workflows through domain-specific linguists, subject-matter experts, and validated processes. This includes terminology management, version control, audit trails, and adherence to global regulatory frameworks, all supported by ISO-certified quality standards.
Life sciences translation includes clinical trial protocols, informed consent forms, investigator brochures, regulatory submissions, labeling, pharmacovigilance reports, and commercialization materials. Each content type requires precision, consistency, and compliance across languages and regions.
Life sciences translation services can integrate directly with clinical trial management systems (CTMS) and other enterprise platforms. This allows content to move efficiently from creation to review to submission while maintaining traceability, version control, and regulatory alignment.
Life sciences translation services are designed to support both speed and compliance. By combining specialized expertise with technology-enabled workflows, organizations can accelerate timelines while maintaining accuracy, consistency, and regulatory standards across global markets.